My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis.

    Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y, Munteanu M, Mercadier A, Manns M, Albrecht J.

    Comp Hepatol. 2005 Dec 23;4:10.PMID: 16375767 [PubMed]Related articlesFree article

    2.

    The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.

    Thabut D, Naveau S, Charlotte F, Massard J, Ratziu V, Imbert-Bismut F, Cazals-Hatem D, Abella A, Messous D, Beuzen F, Munteanu M, Taieb J, Moreau R, Lebrec D, Poynard T.

    J Hepatol. 2006 Jun;44(6):1175-85. Epub 2006 Mar 13.PMID: 16580087 [PubMed - indexed for MEDLINE]Related articles

    3.

    The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.

    Imbert-Bismut F, Naveau S, Morra R, Munteanu M, Ratziu V, Abella A, Messous D, Thabut D, Benhamou Y, Poynard T.

    Eur J Gastroenterol Hepatol. 2009 Jan;21(1):18-27.PMID: 19011575 [PubMed - indexed for MEDLINE]Related articles

    4.

    Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.

    Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, Massard J, Bonyhay L, Tahiri M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V; LIDO Study Group; CYTOL study group.

    BMC Gastroenterol. 2006 Nov 10;6:34.PMID: 17096854 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.

    Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V, Poynard T; LIDO Study Group; CYTOL study group.

    BMC Gastroenterol. 2006 Feb 14;6:6.PMID: 16503961 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B]

    Liu WP, Xu DJ, Zhao LR, Lu ZH, Wang YH, Lang ZW, Wang GQ.

    Zhonghua Nei Ke Za Zhi. 2008 Apr;47(4):308-12. Chinese. PMID: 18843956 [PubMed - indexed for MEDLINE]Related articles

    7.

    Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.

    Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B.

    Comp Hepatol. 2004 Sep 23;3(1):8.PMID: 15387887 [PubMed - as supplied by publisher]Related articlesFree article

    8.

    A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease.

    Halfon P, Imbert-Bismut F, Messous D, Antoniotti G, Benchetrit D, Cart-Lamy P, Delaporte G, Doutheau D, Klump T, Sala M, Thibaud D, Trepo E, Thabut D, Myers RP, Poynard T.

    Comp Hepatol. 2002 Dec 30;1(1):3.PMID: 12537583 [PubMed - as supplied by publisher]Related articlesFree article

    9.

    Factors related to non-alcoholic fatty liver disease in obese children.

    Eminoğlu TF, Camurdan OM, Oktar SO, Bideci A, Dalgiç B.

    Turk J Gastroenterol. 2008 Jun;19(2):85-91.PMID: 19110662 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study.

    Oruc N, Ozutemiz O, Yuce G, Akarca US, Ersoz G, Gunsar F, Batur Y.

    BMC Gastroenterol. 2009 Feb 17;9:16.PMID: 19222849 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.

    Kayadibi H, Gültepe M, Yasar B, Ince AT, Ozcan O, Ipcioglu OM, Kurdas OO, Bolat B, Benek YZ, Guveli H, Atalay S, Ozkara S, Keskin O.

    Dig Dis Sci. 2009 Aug;54(8):1764-71. Epub 2008 Nov 7.PMID: 18989777 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection.

    Hirche TO, Ignee A, Hirche H, Schneider A, Dietrich CF.

    Liver Int. 2007 Aug;27(6):748-57.PMID: 17617117 [PubMed - indexed for MEDLINE]Related articles

    13.

    Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia.

    Ratziu V, Giral P, Munteanu M, Messous D, Mercadier A, Bernard M, Morra R, Imbert-Bismut F, Bruckert E, Poynard T.

    Aliment Pharmacol Ther. 2007 Jan 15;25(2):207-18.PMID: 17229244 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

    Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, Portal I, Allemand I, Bertrand JJ, Rosenthal-Allieri A, Rotily M, Sattonet C, Benderitter T, Saint Paul MC, Bonnot HP, Penaranda G, Degott C, Masseyeff MF, Ouzan D.

    Am J Gastroenterol. 2006 Mar;101(3):547-55.PMID: 16542291 [PubMed - indexed for MEDLINE]Related articles

    15.

    Noninvasive evaluation of graft steatosis in living donor liver transplantation.

    Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, Fujii K, Kiuchi T, Tanaka K.

    Transplantation. 2004 Nov 27;78(10):1501-5.PMID: 15599315 [PubMed - indexed for MEDLINE]Related articles

    16.

    FibroTest-ActiTest as a non-invasive marker of liver fibrosis.

    Halfon P, Munteanu M, Poynard T.

    Gastroenterol Clin Biol. 2008 Sep;32(6 Suppl 1):22-39.PMID: 18973844 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).

    Munteanu M, Messous D, Thabut D, Imbert-Bismut F, Jouys M, Massard J, Piton A, Bonyhay L, Ratziu V, Hainque B, Poynard T.

    Comp Hepatol. 2004 Jun 23;3(1):3.PMID: 15214966 [PubMed - as supplied by publisher]Related articlesFree article

    18.

    Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.

    Soresi M, Tripi S, Franco V, Giannitrapani L, Alessandri A, Rappa F, Vuturo O, Montalto G.

    Liver Int. 2006 Nov;26(9):1119-25.PMID: 17032413 [PubMed - indexed for MEDLINE]Related articles

    19.

    Assessment of liver fibrosis: noninvasive means.

    Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V.

    Saudi J Gastroenterol. 2008 Oct;14(4):163-73.PMID: 19568532 [PubMed]Related articlesFree article

    20.

    Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.

    Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, Olgac V, Sonsuz A, Ozbay G, Yurdakul I, Senturk H.

    Hepatogastroenterology. 2008 Jul-Aug;55(85):1433-8.PMID: 18795706 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk